References
Ang, D., Liberek, K., Skowyra, D., Zylicz, M., and Georgopoulos, C. Biological role and regulation of the universally conserved heat shock proteins. J Biol Chem 266: 24233–24236, 1991
Basombrío, M. A. Search for common antigenicities among 25 sarcomas induced by methylcholanthrene. Cancer Res 30: 2458–2462, 1970
Bevan, M. J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not crossreact in the cytotoxic assay. J Exp Med 143: 1283–1288, 1976
Blachere, N. E., Udono, H., Janetzki, S., Li, Z., Heike, M. and Srivastava, P. K. Heat shock protein vaccines against cancer. J Immunotherapy, in press. 1993
Burnet, F. M. A certain symmetry: histocompatibility antigens compared with immunocyte receptors. Nature 226: 123–126, 1970
Cerundolo, V., Elliott, T., Elvin, J., Bastin, H., Rammensee, H. G., and Townsend, A. The binding affinity and dissociation rates of peptides for MHC class I molecules. Eur J Immunol 21: 2069–2075, 1991
Christnick, E. R., Luscher, M. A., Barber, B. H., and Williams, D. B. Peptide-binding to MHC class I on living cells and quantitation of complexes required for CTL lysis. Nature 352: 67–70, 1991
Darrow, T. L., Slingluff, C. L., and Siegler, H. F. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific T lymphocytes: evidence for shared tumor antigens. J Immunol 142: 3329–3334, 1989
Falk, K., Rötschke, O., and Rammensee, H. G. Cellular peptide composition governed by MHC class I molecules. Nature 348: 248–251, 1990
Feldweg, A. M. and Srivastava, P. K. Molecular heterogeneity of tumor rejection antigen/heat shock protein gp96. J Cell Biochem 170: 108, 1993
Flajnik, M. F., Canel, C., Kramer, J., and Kasahara, M. Which came first, MHC class I or class II? Immunogenetics 33: 295–301, 1991 a
Flajnik, M. F., Canel, C., Kramer, J., and Kasahara, M. Evolution of the MHC: molecular cloning of MHC class I from the amphibian Xenopus, Proc Natl Acad Sci USA 88: 537–541, 1991 b
Flynn, G. C., Chappell, T. G., and Rothman, J. E. Peptide binding and release by proteins implicated as catalysts of protein assembly. Science 245: 385–388, 1989
Flynn, G. C., Pohl, J., Flocco, M. T., and Rothman, J. E. Peptide binding specificity of the molecular chaperone BiP. Nature 353: 726–730, 1991
Forsdyke, D. R. Relationship of X chromosome dosage compensation t to intracellular self/non self discrimination. J Theor Biol, in press, 1993 a
Forsdyke, D. R. The heat shock response and the molecular basis of genetic dominance. J Theor Biol, in press, 1993 b
Globerson, A. and Feldman, M. Antigenic specificity of benzo(a)pyrene induced sarcomas. J Natl Cancer Inst 32: 1229–1243, 1964
Glynne, R., Powis, S. H., Beck, S., Kelly, A., Kerr, L. A., and Trowsdale, J. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353: 357–360, 1991
Gooding, L. R. and Edwards, C.B. H-2 antigen requirement in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J Immunol 124: 1258–1262, 1980
Gooding, L. R. and Wold, W. S. M. Molecular mechanisms by which adenoviruses counteract anti-viral immune defenses. CRC Crit Rev Immunol 10: 53–71, 1989
Griem, P., Wallny, P., Falk, K., Rötzschke, O., Arnold, B., Schonrich, G., Hämmerling, G., and Rammensee, H. G. Uneven distribution of minor histocompatibility proteins versus peptides is caused by MHC expression. Cell 65: 633–640, 1991
Gross, L. Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line. Cancer Res 3: 323–326, 1943
Kawakami, Y., Zakut, R., Topalian, S. L., Stotter, H., and Rosenberg, S. A. Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J Immunol 148: 638–643, 1992
Kelly, A., Powis, S., Glynne, R., Radley, E., Beck, S., and Trowsdale, J. Second proteasome-related gene in the human MHC class II region. Nature 353: 667–668, 1991
Klein, G., Sjogren, H. O., Klein, E., and Hellstrom, K. E. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res 20: 1561–1572, 1960
Lakey, E. K., Margoliash, E., and Pierce, S. K. Identification of a peptide binding protein that plays a role in antigen presentation. Proc Natl Acad Sci USA 84: 1659–1663, 1987
Li, Z. and Srivastava, P. K. Tumor rejection antigen gp96/grp94 is an ATPase: Implications for antigen presentation and protein folding. EMBO J 12: 3143–3151, 1993
Lindquist, S. and Craig, E. A. The heat shock proteins. Annu Rev Genet 22: 631–677, 1988
Moore, S. K., Rijli, F., and Appella, E. Characterization of the mouse 84 kD heat shock protein gene family. DNA Cell Biol 9: 387–400, 1990
Monaco, J. and McDevitt, H. O. The LMP antigens: a stable MHC controlled multi sub unit protein complex. Hum Immunol 15: 416–426, 1986
Oettgen, H. F. and Old, L. J. The historu of cancer immunotherapy. In V. T. De Vita, S. A. Hellman, and S. A. Rosenberg (eds): Biological Therapy of Cancer, pp 87–119, J. B. Lippincott, Philadelphia, 1991
Old, L. J., Boyse, E. A., Clarke, D. A., and Carswell, E. A. Antigenic properties of chemically induced tumors. Ann NY Acad Sci 101: 80–106, 1962
Palladino, M. A., Srivastava, P. K., Oettgen, H. F., and DeLeo, A. B. Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas. Cancer Res 47: 5074–5079, 1987
Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J., and Harding, C. V. Phagocytic processing for bacterial antigens for class I MHC presentation to T cells. Nature 361: 359–362, 1993
Prehn, R. and Main, J. M. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst 18: 769–778, 1957
Raychaudhuri, S. and Morrow, W. J. W. Can soluble antigens induce CD8+ T cell response? A paradox revisited. Immunol Today 14: 344–348, 1993
Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G., and Rammensee, H. G. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348: 252–254, 1990
Rötzschke, O., and Falk, K. Naturally occuring peptide antigens derived from the MHC class I-restricted processing pathway. Immunol Today 12: 447–455, 1991
Rötzschke, O., Falk, K., Faath, S., and Rammensee, H. G. On the nature of proteins involved in T-cell alloreactivity. J Exp Med 174: 1059–1071, 1991
Srivastava, P. K., and Das, M. R. The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen. Int J Cancer 33: 417–422, 1984
Srivastava, P. K. and Heike, M. Tumor-specific immunogenicity of stress-—induced proteins: convergence of two evolutionary pathways of antigen presentation? Semin Immunol 3: 57–64, 1991
Srivastava, P. K. and Maki, R. G. Stress-induced proteins in immune response to cancer. Curr Top Microbiol Immunol 167: 109–123, 1991
Srivastava, P. K. and Old, L. J. Individually distinct transplantation antigens of chemically induced mouse tumors. Immunol Today 9: 78–83, 1988
Srivastava, P. K., De Leo, A. B., and Old, L. J. Tumor rejection antigens of chemically induced tumors of inbred mice. Proc Natl Acad Sci 83: 3407–3807, 1986
Srivastava, P. K., Chen, Y. T., and Old, L. J. 5′ Structural analysis of genes encoding polymorphic antigens of chemically induced tumors. Proc Natl Acad Sci USA 84: 3804–3807, 1987
Tanaka, K., Yoshioka, T., Bieberich, C. and Jay, G. Role of the MHC class I antigens in tumor growth and metastasis. Annu Rev Immunol 6: 359–380, 1988
Townsend, A. and Bodner, H. Antigen presentation by class I-restricted T lymphocytes. Annu Rev Immunol 7: 601–624, 1989
Udono, H. and Srivastava, P. K. Heat shock protein 70-associated peptides elicit cancer-specific immunity. J Exp Med 178: 1391–1396, 1993
Udono, H., Levey, D. L., and Srivastava, P. K. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes naive CD8+ T cells in vivo. Proc Natl Acad Sci USA: in press, 1994
Ullrich, S. J., Robinson, E. A., Law, L. W., Willingham, M., and Appella, E. A mouse tumor-specific transplantation antigen is a heat-shock related protein. Proc Natl Acad Sci USA 83: 3121–3125, 1986
Von Boehmer, H. Developmental biology of T cells in T-cell receptor transgenic mice. Annu Rev Immunol 8: 531–556, 1990
Zinkernagel, R. and Doherty, P. Restriction of in vitro T-cell mediated cutotoxicity in lymphocytic choriomeningitis within a syngeneic or semi-allogeneic system. Nature 248: 701–702, 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Srivastava, P.K., Udono, H., Blachere, N.E. et al. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39, 93–98 (1994). https://doi.org/10.1007/BF00188611
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00188611